MCC
CELG

Mid Continent Capital’s Celgene Corp CELG Stock Holding History

Mid Continent Capital’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-3,426
Closed -$294K – 327
2014
Q2 		$294K Sell
3,426
-4,000
-54% -$304K 0.02% 273
2014
Q1 		$518K Sell
7,426
-4,800
-39% -$380K 0.03% 221
2013
Q4 		$1.03M Buy
+12,226
New +$967K 0.06% 173

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Mid Continent Capital's CELG Position: Q3 2014 in Review

Mid Continent Capital sold out of Celgene Corp (CELG) in Q3 2014, closing a stake of 3,426 shares — an estimated $294K sold.

Mid Continent Capital first reported a position in CELG in Q4 2013 and held it in 3 quarters. The position peaked at $1.03M in Q4 2013. 1,031 funds tracked by Wall St. Rank hold CELG as of Q3 2014.

  • Mid Continent Capital reported no remaining Celgene Corp position as of Q3 2014 after selling out during the quarter.
  • Mid Continent Capital sold 3,426 Celgene Corp shares in Q3 2014, an estimated $294K.
  • Mid Continent Capital first reported a position in Celgene Corp in Q4 2013 and held it in 3 quarters.
  • Mid Continent Capital's Celgene Corp position peaked at $1.03M in Q4 2013.
  • 1,031 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2014.

Based on Mid Continent Capital's 13F filing for Q3 2014, filed 28 Oct 2014.